| Application no. and date | 18816468.5 (espacenet) (Federated) (European Patent Register), 20181130 | | Patent/reg. no. and date | DK/EP 3717455, 20241120 | | Publication date | 20201007 | | Priority no. and date | EP 17382829, 20171201 | | EP pub. no. and date |
EP 3717455 20201007 | | Effective date | | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | | Applicant ref. no. | | | Inventor | MORGAN, Adam, 14 Oak Ridge Lane
Ashland, MA 01721, US,
LEMERCIER LEWANDOWSKI, Berenice, 50 Northern Avenue
Boston, MA 02210, US,
LEWIS, Robert, 99 Hayden Avenue
Lexington, MA 02421, US,
LOOKER, Adam, 50 Northern Avenue
Boston, MA 02210, US,
ROEPER, Stefanie, 50 Northern Avenue
Boston, MA 02210, US,
RYAN, Michael, 50 Northern Avenue
Boston, MA 02210, US,
SOLSONA ROCABERT, Juan, Gabriel, Caracas
17-19
08030 Barcelona, ES,
WILDE, Nathan, 50 Northern Avenue
Boston, MA 02210, US | | Representative | | | Opponent | | | IPC Class | C07B 59/00 (2006.01) , C07C 33/18 (2006.01) , C07C 69/96 (2006.01) , C07D 215/56 (2006.01) | | Title | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | | Int. application no. | US2018063451 | | Int. publication no. | WO2019109021 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
